Over a week ago |
On The Fly
|
Check out this morning's… ShowHide Related Items >><< - 03/10/23
- X4 Pharmaceuticals says held about 2.5% of cash deposits at SVB
- 12/12/22
- X4 Pharmaceuticals presents on Mavorixafor at ASH 2022
- 11/29/22
- X4 Pharmaceuticals announces 4WHIM trial meets primary endpoint
- 11/03/22
- X4 Pharmaceuticals Chief Medical Officer, Dr. Diego Cadavid, to depart
- 02/08/23
- Tencent Music announces integration of TME UNI Chart on Billboard's website
- 01/30/23
- Tencent Music falls -8.2%
- 01/30/23
- Tencent Music falls -10.0%
- 11/15/22
- Tencent Music rises 25.6%
- 03/21/23
- On Holding up 17% in pre-market trading at $25.21 after Q4 results and guidance
- 03/15/23
- Facebook Ireland violated law over data use, Amsterdam court ruled
- 03/15/23
- Oportun Financial expands executive team with key new hires
- 03/14/23
- Meta targeting summer to complete analysis from hybrid work year of learning
- 03/14/23
- Meta Platforms canceling projects that are lower priority, duplicative
- 03/21/23
- Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/16/23
- First Republic confirms it will receive deposits totaling $30B from banks
- 03/16/23
- Fed, Treasury say banks' deposits in First Republic show system's 'resilience'
- 02/01/23
- Huya rises 12.2%
- 02/01/23
- Huya rises 11.1%
- 01/19/23
- Huya rises 8.2%
- 12/28/22
- Huya falls -16.7%
- $12.15 /
-10.84 (-47.15%) - 03/20/23
- First Republic paused again for volatility after dropping 46% to $12.41
- 03/20/23
- First Republic extends decline, shares down 37% to $14.59
- 03/20/23
- First Republic down 30% after WSJ report of bank CEOs stabilization talks
- 03/20/23
- First Republic falls -18.1%
- 03/14/23
- Emerson Electric selected to automate photovoltaic project in New Zealand
- 03/13/23
- Emerson selected to automate Golden Triangle Polymers facility
- 01/23/23
- Emerson Electric issues statement regarding National Instruments proposal
- 01/17/23
- National Instruments reiterates commitment to strategic review process
- 03/21/23
- Canadian Solar up 9% at $39.02 in pre-market after Q4 earnings beat
- 03/07/23
- Canadian Solar reports commercial operation of three solar projects in Japan
- 03/06/23
- Canadian Solar receives favorable EIA for 685 MW in Spain
- 02/27/23
- Canadian Solar renews EUR 100M note program
- 03/20/23
- First Majestic falls 17% after announcing cost cuts, suspended mining activity
- 03/20/23
- First Majestic to reduce costs, suspend mining activities at Jerritt Canyon
- 11/28/22
- Metalla to acquire royalty portfolio from First Majestic for $20M
- 03/21/23
- ProFrac Holding provides outlook for 2023
- 02/27/23
- ProFrac acquires Performance Proppants, upsizes ABL Credit Facility
- 12/27/22
- ProFrac Holding to acquire REV Energy, Performance Holdings
- 12/05/22
- ProFrac Holding to acquire Eagle Ford sand mining operations of Monarch Silica
- $12.15 /
-10.84 (-47.15%) - 03/21/23 Goldman Sachs
- First Republic rating suspended at Goldman Sachs
- 03/20/23 Evercore ISI
- Evercore ISI suspends rating on First Republic in light of uncertainty
- 03/20/23 Morgan Stanley
- Morgan Stanley removes First Republic price target amid 'wide range of outcomes'
- 03/17/23 Atlantic Equities
- First Republic downgraded to Neutral from Overweight at Atlantic Equities
- 03/21/23 Morgan Stanley
- Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley
- 03/20/23 Loop Capital
- Meta Platforms price target raised to $220 from $188 at Loop Capital
- 03/20/23 Edward Jones
- Meta Platforms upgraded to Buy from Hold at Edward Jones
- 03/17/23 TD Cowen
- Meta Platforms price target raised to $190 from $175 at TD Cowen
- 03/21/23 Morgan Stanley
- Emerson Electric upgraded to Overweight from Equal Weight at Morgan Stanley
- 03/06/23 UBS
- Emerson Electric upgraded to Buy from Neutral at UBS
- 02/21/23 TD Cowen
- Emerson Electric price target lowered to $105 from $115 at Cowen
- 02/14/23 Argus
- Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
- 03/09/23 Citi
- Canadian Solar transferred at Neutral from Buy at Citi
- 03/09/23 Citi
- Canadian Solar downgraded to Neutral from Buy at Citi
- 02/09/23 Wells Fargo
- Canadian Solar price target raised to $46 from $33 at Wells Fargo
- 01/30/23 Goldman Sachs
- Canadian Solar price target raised to $36 from $33 at Goldman Sachs
- 01/12/23 JPMorgan
- ProFrac Holding price target raised to $32 from $30 at JPMorgan
- 01/10/23 Piper Sandler
- ProFrac Holding price target raised to $35 from $31.50 at Piper Sandler
- 12/28/22 Stifel
- ProFrac Holding addition of new assets a positive, says Stifel
- 11/14/22 Stifel
- ProFrac Holding price target raised to $38 from $29 at Stifel
- 01/19/23 86 Research
- Tencent Music downgraded to Hold from Buy at 86 Research
- 12/01/22 Morgan Stanley
- Tencent Music upgraded at Morgan Stanley with sustainable growth ahead
- 12/01/22 Morgan Stanley
- Tencent Music upgraded to Overweight from Equal Weight at Morgan Stanley
- 11/22/22 JPMorgan
- Tencent Music upgraded to Overweight from Neutral at JPMorgan (yesterday)
- 02/02/23 HSBC
- Huya price target raised to $6.30 from $4.60 at HSBC
- 12/13/22 China Renaissance
- China Renaissance upgrades Huya on end of regulation tightening
- 12/13/22 China Renaissance
- Huya upgraded to Buy from Hold at China Renaissance
- 11/16/22 Citi
- Huya downgraded to Sell at Citi on slower industry outlook
- 12/22/22 Cantor Fitzgerald
- X4 Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
- 12/11/22 Piper Sandler
- X4 Pharmaceuticals initiated with an Overweight at Piper Sandler
- 11/30/22 H.C. Wainwright
- X4 Pharmaceuticals price target raised to $5 from $3.50 at H.C. Wainwright
- 08/05/22 H.C. Wainwright
- X4 Pharmaceuticals price target lowered to $3.50 from $8.50 at H.C. Wainwright
- 02/27/23 TD Securities
- First Majestic price target lowered to C$11 from C$12 at TD Securities
- 02/14/23 National Bank
- First Majestic price target lowered to C$11 from C$14.50 at National Bank
- 01/20/23 BMO Capital
- First Majestic price target lowered to C$9 from C$10.50 at BMO Capital
- 01/13/23 National Bank
- First Majestic price target raised to C$14.50 from C$13 at National Bank
- 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 02/08/23 Keefe Bruyette
- Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform
- 03/16/23 Wedbush
- Wedbush upgrades On Holding to Outperform, raises price target to $25
- 03/16/23 Wedbush
- On Holding upgraded to Outperform from Neutral at Wedbush
- 03/13/23 UBS
- On Holding price target raised to $27 from $25 at UBS
- 01/04/23 Piper Sandler
- Wolverine World Wide downgraded to Neutral from Overweight at Piper Sandler
- 03/21/23
- X4 Pharmaceuticals reports Q4 EPS (29c), consensus (24c)
- 11/03/22
- X4 Pharmaceuticals reports Q3 EPS (26c), consensus (30c)
- 03/21/23
- Tencent Music reports Q4 EPS 11c, consensus 13c
- 11/15/22
- Tencent Music reports Q3 EPS 12c, consensus 10c
- 03/21/23
- On Holding sees FY23 revenue of 'at least' CHF 1.7B vs. CHF 1.22B last year
- 03/21/23
- On Holding reports Q4 EPS CHF0.02 vs. (CHF0.04) last year
- 11/16/22
- On Holding raises FY22 revenue view to CHF 1.125B from CHF 1.1B
- 11/16/22
- On Holding reports Q3 EPS CHF0.06 vs. CHF0.04 last year
- 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 03/21/23
- Huya reports Q4 EPS (26c), consensus (30c)
- 11/15/22
- Huya reports Q3 EPS 6c, consensus (3c)
- $12.15 /
-10.84 (-47.15%) - 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 02/08/23
- Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08
- 02/08/23
- Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00
- 02/08/23
- Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c
- 10/31/22
- Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08
- 03/21/23
- Canadian Solar sees FY23 revenue $8.5B-$9.5B, consensus $9.88B
- 03/21/23
- Canadian Solar sees Q1 revenue $1.6B-$1.8B, consensus $1.95B
- 03/21/23
- Canadian Solar reports Q4 EPS $1.11, consensus 76c
- 02/24/23
- Canadian Solar sees Q1 revenue $1.6B_$1.8B, consensus $2.04B
- 03/21/23
- ProFrac Holding reports Q4 EPS 82c, consensus 88c
- 11/10/22
- ProFrac Holding sees Q4 revenue above Q3, consensus $755.54M
- 11/10/22
- ProFrac Holding reports Q3 EPS $1.09, consensus 86c
|
Upgrade
|
Morgan Stanley upgraded… Morgan Stanley upgraded Emerson Electric (EMR) to Overweight from Equal Weight with a price target of $96, up from $95. The stock's risk/reward is among the best in the sector with the National Instruments (NATI) resolution potentially being a "win-win as management lands an accretive deal or establishes its discipline," the analyst tells investors in a research note. The firm says Emerson's fundamentals are accelerating, particularly with liquified natural gas and hydrogen. It sees an attractive risk/reward at current share levels. ShowHide Related Items >><< NATI National Instruments - 03/06/23
- National Instruments acquires SET GmbH, terms undisclosed
- 01/17/23
- National Instruments confirms receipt of acquisition proposal from Emerson
- 03/14/23
- Emerson Electric selected to automate photovoltaic project in New Zealand
- 03/13/23
- Emerson selected to automate Golden Triangle Polymers facility
- 01/23/23
- Emerson Electric issues statement regarding National Instruments proposal
- 01/17/23
- National Instruments reiterates commitment to strategic review process
- 03/06/23 UBS
- Emerson Electric upgraded to Buy from Neutral at UBS
- 02/21/23 TD Cowen
- Emerson Electric price target lowered to $105 from $115 at Cowen
- 02/14/23 Argus
- Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
- 02/14/23 Argus
- Emerson Electric downgraded to Hold from Buy at Argus
NATI National Instruments - 02/01/23 Baird
- National Instruments downgraded to Neutral from Outperform at Baird
- 01/18/23 Baird
- Aspen Technology price target lowered to $224 from $242 at Baird
- 01/17/23 Deutsche Bank
- Emerson makes hostile bid for National Instruments, says Deutsche Bank
NATI National Instruments - 01/31/23
- National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c
- 01/31/23
- National Instruments reports Q4 adjusted EPS 63c, consensus 64c
- 10/27/22
- National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c
- 10/27/22
- National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c
- 02/08/23
- Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08
- 02/08/23
- Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00
- 02/08/23
- Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c
- 10/31/22
- Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08
- 10/31/22
- Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
NATI National Instruments - 01/17/23
- What You Missed On Wall Street This Morning
- 01/13/23
- What You Missed On Wall Street On Friday
- 03/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/08/23
- What You Missed On Wall Street This Morning
- 02/08/23
- Fly Intel: Pre-market Movers
- 01/17/23
- What You Missed On Wall Street On Tuesday
NATI National Instruments - 03/17/23
- National Instruments put volume heavy and directionally bearish
- 03/01/23
- National Instruments call volume above normal and directionally bullish
|
Hot Stocks
|
Emerson will provide… Emerson will provide advanced automation solutions to New Zealand's first large-scale solar photovoltaic power project within New Zealand's goal of achieving carbon neutrality by 2050. Emerson's renewable power generation expertise will help solar energy company Lodestone Energy complete its two 23 MW sites at Kaitaia and Edgecumbe. ShowHide Related Items >><< - 03/13/23
- Emerson selected to automate Golden Triangle Polymers facility
- 01/23/23
- Emerson Electric issues statement regarding National Instruments proposal
- 01/17/23
- National Instruments reiterates commitment to strategic review process
- 01/17/23
- National Instruments confirms receipt of acquisition proposal from Emerson
- 03/06/23 UBS
- Emerson Electric upgraded to Buy from Neutral at UBS
- 02/21/23 TD Cowen
- Emerson Electric price target lowered to $105 from $115 at Cowen
- 02/14/23 Argus
- Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
- 02/14/23 Argus
- Emerson Electric downgraded to Hold from Buy at Argus
- 02/08/23
- Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08
- 02/08/23
- Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00
- 02/08/23
- Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c
- 10/31/22
- Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08
- 10/31/22
- Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 03/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/08/23
- What You Missed On Wall Street This Morning
- 02/08/23
- Fly Intel: Pre-market Movers
- 01/17/23
- What You Missed On Wall Street On Tuesday
|
Hot Stocks
|
Emerson (EMR) will… Emerson (EMR) will provide automation technologies, software and analytics from its Plantweb digital ecosystem for the Golden Triangle Polymers Project, a world-scale integrated polymers facility on the Texas Gulf Coast. The total installed cost of the project is expected to be $8.5 billion and is a joint venture between Chevron Phillips Chemical Company, a company owned by Chevron (CVX) and Phillips 66 (PSX), and an indirect subsidiary of QatarEnergy. Operations are expected to begin in 2026. "The Golden Triangle Polymers Project and the recently announced Ras Laffan Petrochemical Complex in Qatar are among the world's largest ethane crackers, both leveraging Emerson's digital automation technologies, software and expertise to promote safer, smarter and more sustainable operations," said Ron Martin, Emerson's president, Americas. "We are proud to support Chevron Phillips Chemical's and QatarEnergy's track record of building world-class, optimized facilities." ShowHide Related Items >><< - 02/08/23
- Phillips 66 raises quarterly dividend 8% to $1.05 per share
- 01/31/23
- Phillips 66 falls -6.0%
- 01/31/23
- Phillips 66 falls -4.8%
- 01/24/23
- Phillips 66 trading resumes
- 01/23/23
- Emerson Electric issues statement regarding National Instruments proposal
- 01/17/23
- National Instruments reiterates commitment to strategic review process
- 01/17/23
- National Instruments confirms receipt of acquisition proposal from Emerson
- 01/17/23
- Emerson Electric 'disappointed' National Instruments chose to announce review
- 03/07/23
- Chevron, JERA sign MOU to explore carbon capture projects in U.S., Australia
- 03/06/23
- Bayou Bend expands carbon capture project to onshore Southeast Texas
- 02/28/23
- Chevron CEO: We're investing to grow and growing faster than the market
- 02/28/23
- Chevron reaffirms long-term objectives at investor meeting
- 03/06/23 UBS
- Emerson Electric upgraded to Buy from Neutral at UBS
- 02/21/23 TD Cowen
- Emerson Electric price target lowered to $105 from $115 at Cowen
- 02/14/23 Argus
- Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
- 02/14/23 Argus
- Emerson Electric downgraded to Hold from Buy at Argus
- 03/10/23 Mizuho
- Chevron price target raised to $206 from $200 at Mizuho
- 03/02/23 Wells Fargo
- Chevron price target lowered to $199 from $204 at Wells Fargo
- 02/24/23 TD Cowen
- Chevron price target lowered to $170 from $185 at Cowen
- 01/31/23 Truist
- Chevron price target raised to $179 from $169 at Truist
- 03/10/23 Mizuho
- Phillips 66 price target lowered to $120 from $121 at Mizuho
- 03/08/23 UBS
- UBS starts eight independent refiners with three Buys
- 03/08/23 UBS
- Phillips 66 initiated with a Buy at UBS
- 01/12/23 Mizuho
- DCP Midstream downgraded on Phillips 66 buyout at Mizuho
- 01/31/23
- Phillips 66 reports Q4 EPS $4.00, consensus $4.35
- 11/01/22
- Phillips 66 reports Q3 EPS $6.46, consensus $4.91
- 02/08/23
- Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08
- 02/08/23
- Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00
- 02/08/23
- Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c
- 10/31/22
- Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08
- 01/27/23
- Chevron reports Q4 adjusted EPS $4.09, consensus $4.38
- 01/26/23
- Notable companies reporting before tomorrow's open
- 10/28/22
- Chevron reports Q3 adjusted EPS $5.56, consensus $4.81
- 01/17/23
- Phillips 66 says Borger fire out, six hurt, Bloomberg reports
- 01/17/23
- Fire at Phillips 66 complex leaves 3 injured, closes highway, ABC 7 News says
- 11/30/22
- EPA to propose boost in biofuel quotas, Reuters reports
- 11/30/22
- President Biden plans to boost biofuel quotas for next 3 years, Bloomberg says
- 10/31/22
- Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 02/06/23
- Chevron looks to seal energy exploration deal with Algeria, WSJ reports
- 01/18/23
- U.S. Energy Secretary warns GOP of oil bill risks, Reuters says
- 01/10/23
- ExxonMobil led group develops1.3B barrel off shore Guyana field, AP reports
- 01/03/23
- Exxon, Chevron shift focus to oil projects in the Americas, WSJ reports
- 03/09/23
- What You Missed On Wall Street On Thursday
- 03/09/23
- What You Missed On Wall Street This Morning
- 10/27/22
- What You Missed On Wall Street On Thursday
- 10/27/22
- What You Missed On Wall Street This Morning
- 03/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/08/23
- What You Missed On Wall Street This Morning
- 02/08/23
- Fly Intel: Pre-market Movers
- 01/17/23
- What You Missed On Wall Street On Tuesday
- 02/28/23
- Fly Intel: Pre-market Movers
- 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 01/27/23
- What You Missed On Wall Street On Friday
- 03/09/23
- Early notable gainers among liquid option names on March 9th
- 02/17/23
- Phillips 66 put volume heavy and directionally bearish
- 10/07/22
- Phillips 66 put volume heavy and directionally bearish
- 09/13/22
- Phillips 66 call volume above normal and directionally bullish
- 03/10/23
- Early notable gainers among liquid option names on March 10th
- 01/27/23
- Unusually active option classes on open January 27th
- 01/26/23
- Unusually active option classes on open January 26th
- 10/20/22
- Unusually active option classes on open October 20th
|
On The Fly
|
Want to get stock-moving… ShowHide Related Items >><< - 03/03/23
- Trian Fund cuts Wendy's stake to 17.85% from 19.52%
- 03/01/23
- Wendy's sees FY23 CapEx $75M-$85M
- 03/01/23
- Wendy's announces plan to redesign organizational structure
- 03/01/23
- Wendy's reports Q4 U.S. systemwide sales growth of 7.2%
- 02/23/23
- Vir Biotechnology shares fall over 5% after missing quarterly estimates
- 02/22/23
- Vir Biotechnology announces final draft guidance on sotrovimab from U.K.'s NICE
- 02/16/23
- Vir Biotechnology appoints Sung Lee as Chief Financial Officer
- 02/13/23
- Vir Biotechnology announces amended collaboration pact with GSK
- 03/06/23
- Silvergate Capital falls -9.6%
- 03/06/23
- Silvergate falls after discontinuing Silvergate Exchange Network
- 03/03/23
- Silvergate Capital falls -6.4%
- 03/02/23
- Silvergate Capital falls -44.7%
- 02/03/23
- RH says certain financial statements 'should no longer be relied upon'
- 02/03/23
- RH sees FY22 revenue growth at low end of prior range of (3.5%)-(4.5%)
- 12/08/22
- RH says Q3 gross margin contracted 50bps
- 12/08/22
- RH to acquire Dmitriy & Co
- 03/02/23
- Cue Health announces new COVID-19 awareness collaboration with Pfizer
- 02/28/23
- Pfizer gets positive FDA AdCom votes for PF-06928316
- 02/24/23
- Pfizer treatment of pulmonary arterial hypertension gets FDA orphan designation
- 02/22/23
- Pfizer's elranatamab receives FDA and EMA filing acceptance
NATI National Instruments - 03/06/23
- National Instruments acquires SET GmbH, terms undisclosed
- 02/16/23
- Meritage Homes initiates quarterly dividend of 27c per share
- 02/01/23
- Meritage Homes reports Q4 EPS $7.09, consensus $7.00
- 10/26/22
- Meritage Homes sees Q4 home closings 4,300-4,700
- 09/29/22
- Meritage Homes releases second annual ESG report
- 03/06/23
- Merck: FDA approves IM route of administration for MMRV family of vaccines
- 03/02/23
- Illumina and Myriad Genetics partner for HRD testing in the U.S.
- 03/02/23
- AstraZeneca says FDA to convene AdCom meeting on sNDA for Lynparza in mCRPC
- 03/01/23
- BeyondSpring enrolls first patient in study of Plinabulin, Keytruda, Docetaxel
- 02/28/23
- Monster Beverage announces 2-for-1 split, effective March 28
- 11/03/22
- Monster Beverage announces new $500M share repurchase program
- 10/27/22
- MSG Sports, MSG Entertainment enter marketing partnership with Monster Energy
- 10/10/22
- VPX Sports, maker of Bang Energy drinks, seeks Chapter 11 bankruptcy protection
- 03/03/23
- Eli Lilly says FDA broadens indication for Verzenio
- 03/01/23
- Eli Lilly cuts insulin prices by 70%, caps out of pocket costs
- 02/23/23
- Nektar reports Phase 2 data on rezpegaldesleukin in lupus
- 02/13/23
- Eli Lilly to supply API for insulin at reduced price to IABL
- 01/11/23
- KB Home falls 5% to $34.20 after Q4 earnings miss and guidance
- 01/11/23
- KB Home sees 2023 housing revenue at $5.0B-$6.0B vs. $6.88B in 2022
- 01/11/23
- KB Home sees Q1 housing revenue at $1.25B-$1.40B
- 01/11/23
- KB Home reports Q4 gross orders down 47%
HR Healthcare Realty Trust - 01/31/23
- Healthcare Realty Trust completes $112.M in asset sales to fund special dividend
- 02/23/23
- HashiCorp exec sells $1.16M in common stock
- 02/01/23
- PowerSchool appoints Paul Brook as CCO
- 12/07/22
- HashiCorp jumps 10% to $29.43 after Q3 earnings beat and guidance raise
- 10/19/22
- Intel announces new cloud collaboration with HashiCorp
- 01/23/23
- Emerson Electric issues statement regarding National Instruments proposal
- 01/17/23
- National Instruments reiterates commitment to strategic review process
- 01/17/23
- National Instruments confirms receipt of acquisition proposal from Emerson
- 01/17/23
- Emerson Electric 'disappointed' National Instruments chose to announce review
- 02/13/23
- Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4
- 01/24/23
- D.R. Horton saw 'slight' improvement in cancellation rate in January
- 01/24/23
- D.R. Horton: Goal is to generate FY23 revenue slightly higher than FY22
- 12/15/22
- D.R. Horton acquires homebuilding operations of Riggins Custom Homes
- 03/03/23
- Bristol-Myers receives EC approval of Reblozyl
- 03/02/23
- Bristol-Myers and Johnson & Johnson launch Phase 3 trial of milvexian
- 02/28/23
- Bristol-Myers: FDA accepts sBLA for Opdivo
- 02/17/23
- Bristol-Myers announces three-year results from Phase 3 CheckMate-274 trial
- 02/28/23
- Globalstar spikes 10% after disclosing $252M loan from Apple
- 02/22/23
- Apple prepares to allow outside app stores or 'sideloading,' Bloomberg reports
- 02/16/23
- T-Mobile announces launch of MLS Season Pass on Apple TV app
- 02/14/23
- Berkshire added more of top-holding Apple, Paramount in Q4
- 03/06/23 Redburn
- Monster Beverage upgraded to Buy from Neutral at Redburn
- 03/01/23 BMO Capital
- Monster Beverage price target raised to $105 from $97 at BMO Capital
- 03/01/23 Truist
- Monster Beverage price target raised to $120 from $100 at Truist
- 03/01/23 Citi
- Monster Beverage price target lowered to $118 from $121 at Citi
- 03/06/23 Needham
- Needham upgrades HashiCorp to Buy on conservative 2023 estimates
- 03/06/23 Needham
- HashiCorp upgraded to Buy from Hold at Needham
- 02/24/23 Scotiabank
- HashiCorp initiated with a Sector Perform, $34 target at Scotiabank
- 02/23/23 Scotiabank
- HashiCorp initiated with a Sector Perform at Scotiabank
- 03/06/23 UBS
- Emerson Electric upgraded to Buy from Neutral at UBS
- 02/21/23 TD Cowen
- Emerson Electric price target lowered to $105 from $115 at Cowen
- 02/14/23 Argus
- Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
- 02/14/23 Argus
- Emerson Electric downgraded to Hold from Buy at Argus
NATI National Instruments - 02/01/23 Baird
- National Instruments downgraded to Neutral from Outperform at Baird
- 01/18/23 Baird
- Aspen Technology price target lowered to $224 from $242 at Baird
- 01/17/23 Deutsche Bank
- Emerson makes hostile bid for National Instruments, says Deutsche Bank
- 03/06/23 JPMorgan
- Meritage Homes upgraded to Overweight from Neutral at JPMorgan
- 11/22/22 JPMorgan
- Meritage Homes price target raised to $90 from $78 at JPMorgan
- 11/14/22 KeyBanc
- Meritage Homes price target raised to $96 from $87 at KeyBanc
- 10/10/22 Wedbush
- Meritage Homes price target lowered to $102 from $130 at Wedbush
- 03/06/23 H.C. Wainwright
- Vir Biotechnology price target lowered to $100 from $125 at H.C. Wainwright
- 03/06/23 JPMorgan
- Vir Biotechnology upgraded to Overweight from Neutral at JPMorgan
- 02/21/23 Goldman Sachs
- Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs
- 01/27/23 Morgan Stanley
- Vir Biotechnology upgraded to Equal Weight from Underweight at Morgan Stanley
- 03/06/23 Northcoast
- Wendy's downgraded to Neutral at Northcoast on profit headwinds, share risk
- 03/06/23 Northcoast
- Wendy's downgraded to Neutral from Buy at Northcoast
- 01/17/23 Truist
- Wendy's price target raised to $28 from $27 at Truist
- 01/16/23 Deutsche Bank
- Wendy's downgraded to Hold from Buy at Deutsche Bank
- 03/06/23 Jefferies
- RH cut to Hold at Jefferies with luxury housing market 'struggling to stabilize'
- 03/06/23 Jefferies
- RH downgraded to Hold from Buy at Jefferies
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- RH assumed with an Equal Weight at Barclays
- 03/06/23 Compass Point
- Silvergate Capital downgraded to Sell from Neutral at Compass Point
- 03/06/23 Wedbush
- Wedbush downgrades Silvergate Capital to Underperform, lowers price target to $4
- 03/06/23 Wedbush
- Silvergate Capital downgraded to Underperform from Neutral at Wedbush
- 03/02/23 Goldman Sachs
- Goldman suspends Silvergate rating on 'insufficient information'
- 03/06/23 JPMorgan
- D.R. Horton downgraded to Neutral from Overweight at JPMorgan
- 01/25/23 BTIG
- D.R. Horton price target raised to $108 from $101 at BTIG
- 01/25/23 JMP Securities
- D.R. Horton price target raised to $115 from $95 at JMP Securities
- 01/25/23 Wedbush
- Wedbush downgrades D.R. Horton to Neutral, lowers price target to $96
- 03/06/23 JPMorgan
- KB Home downgraded to Underweight from Overweight at JPMorgan
- 01/13/23 BTIG
- KB Home earnings miss driven by fewer deliveries, says BTIG
- 01/13/23 RBC Capital
- KB Home downgraded to Sector Perform from Outperform at RBC Capital
- 01/12/23 UBS
- KB Home price target lowered to $45 from $48 at UBS
HR Healthcare Realty Trust - 03/06/23 Credit Suisse
- Healthcare Realty Trust downgraded to Neutral from Outperform at Credit Suisse
- 01/30/23 Citi
- Citi opens 'Catalyst Watches' into REITs, lodging earnings reports
- 12/14/22 Citi
- Healthcare Realty Trust downgraded to Neutral from Buy at Citi
- 11/10/22 Barclays
- Healthcare Realty Trust price target lowered to $28 from $33 at Barclays
- 03/06/23 BofA
- Apple App Store revenue growth 'still muted' in fiscal Q2-to-date, says BofA
- 03/05/23 Goldman Sachs
- Apple initiated with a Buy at Goldman Sachs
- 03/03/23 Barclays
- Google facing query share loss for first time ever, says Barclays
- 03/03/23 Morgan Stanley
- Morgan Stanley sees catalysts for top pick Apple, ups price target
- 03/06/23 Jefferies
- Jefferies starts 'optically cheap' Bristol-Myers at Hold on structural concerns
- 03/06/23 Jefferies
- Bristol-Myers initiated with a Hold at Jefferies
- 01/19/23 Piper Sandler
- Amgen price target cut at Piper on lower Otezla estimates
- 01/17/23 Cantor Fitzgerald
- Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
- 03/06/23 Jefferies
- Jefferies starts Pfizer with a Hold on lack of visibility
- 03/06/23 Jefferies
- Pfizer initiated with a Hold at Jefferies
- 03/03/23 SVB Securities
- SVB says Pfizer could create value for holders with Seagen bid up to $253
- 02/28/23 Oppenheimer
- Seagen price target raised to $210 from $180 at Oppenheimer
- 03/06/23 Jefferies
- Jefferies starts 'priced to perfection' Eli Lilly with a Hold
- 03/06/23 Jefferies
- Eli Lilly initiated with a Hold at Jefferies
- 03/02/23 Morgan Stanley
- Novo Nordisk named 'Catalyst Driven Idea' at Morgan Stanley
- 02/24/23 Jefferies
- Nektar downgraded to Underperform from Hold at Jefferies
- 03/06/23 Jefferies
- Merck initiated with a Buy at Jefferies
- 02/23/23 JPMorgan
- Merck shares positioned for further upside, says JPMorgan
- 02/22/23 Wolfe Research
- Wolfe upgrades Merck with pipeline 'big enough to matter'
- 03/01/23
- Wendy's sees FY23 adjusted EPS 95c-$1.00, consensus $1.00
- 03/01/23
- Wendy's reports Q4 adjusted EPS 22c, consensus 20c
- 02/28/23
- Notable companies reporting before tomorrow's open
- 02/23/23
- Vir Biotechnology reports Q4 EPS (76c), consensus (39c)
- 11/03/22
- Vir Biotechnology reports Q3 EPS $1.30, consensus (21c)
- 01/17/23
- Silvergate Capital reports Q4 adjusted EPS 48c, consensus 81c
- 10/18/22
- Silvergate Capital reports Q3 EPS $1.28, consensus $1.38
- 12/08/22
- RH narrow FY22 revenue growth view to down 4.5% to down 3.5%
- 12/08/22
- RH reports Q3 EPS $5.67, consensus $4.70
- 12/08/22
- Notable companies reporting after market close
- 09/08/22
- RH sees Q3 revenue down 18% to down 15%
- 01/31/23
- Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44
- 01/31/23
- Pfizer reports Q4 adjusted EPS $1.14, consensus $1.05
- 01/30/23
- Notable companies reporting before tomorrow's open
NATI National Instruments - 01/31/23
- National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c
- 01/31/23
- National Instruments reports Q4 adjusted EPS 63c, consensus 64c
- 10/27/22
- National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c
- 10/27/22
- National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c
- 10/26/22
- Meritage Homes sees Q4 adjusted EPS $6.50-$7.40, consensus $6.92
- 10/26/22
- Meritage Homes reports Q3 EPS $7.10, consensus $6.45
- 02/28/23
- NGM Biopharmaceuticals reports Q4 EPS (45c), consensus (51c)
- 02/02/23
- Merck sees FY23 adjusted EPS $6.80-$6.95, consensus $7.36
- 02/02/23
- Merck reports Q4 adjusted EPS $1.62, consensus $1.54
- 02/28/23
- Monster Beverage reports Q4 EPS 57c, consensus 63c
- 02/28/23
- Notable companies reporting after market close
- 11/03/22
- Monster Beverage reports Q3 EPS 60c, consensus 59c
- 11/03/22
- Notable companies reporting after market close
- 02/02/23
- Eli Lilly raises FY23 adjusted EPS view to $8.35-$8.55 from $8.10-$8.30
- 02/02/23
- Eli Lilly reports Q4 adjusted EPS $2.09, consensus $1.78
- 01/11/23
- KB Home reports Q4 EPS $2.47, consensus $2.87
- 09/21/22
- KB Home sees Q4 housing revenue $1.95B-$2.05B
- 09/21/22
- KB Home reports Q3 EPS $2.86, consensus $2.67
- 09/21/22
- Notable companies reporting after market close
HR Healthcare Realty Trust - 03/01/23
- Healthcare Realty Trust reports Q4 normalized FFO 42c, consensus 40c
- 11/09/22
- Healthcare Realty Trust reports Q3 normalized FFO 39c, consensus 42c
- 12/07/22
- HashiCorp raises FY23 EPS view to (71c)-(69c) from (97c)-(95c), consensus (96c)
- 12/07/22
- HashiCorp sees Q4 EPS (23c)-(21c), consensus (30c)
- 12/07/22
- HashiCorp reports Q3 EPS (13c), consensus (31c)
- 02/08/23
- Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08
- 02/08/23
- Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00
- 02/08/23
- Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c
- 10/31/22
- Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08
- 01/24/23
- D.R. Horton sees Q2 revenue $6.3B-$6.7B, consensus $6.53B
- 01/24/23
- D.R. Horton reports Q1 EPS $2.76, consensus $2.26
- 01/23/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00
- 02/02/23
- Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72
- 02/01/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
- 09/16/22
- WHO panel recommends against GSK, Regeneron COVID drugs, Bloomberg reports
- 03/03/23
- Silvergate Capital suspending Silvergate exchange network, Bloomberg says
- 03/03/23
- FHLB says Silvergate advances 'fully repaid,' American Banker reports
- 03/02/23
- Coinbase, Galaxy drop Silvergate after going concern filing, Reuters reports
- 02/16/23
- Binance had secret access to U.S. partner account at Silvergate, Reuters says
- 02/28/23
- FDA advisors back safety of Pfizer RSV vaccine
- 02/27/23
- Pfizer in talks to buy Seagen in deal that may be valued at over $30B, WSJ says
- 02/04/23
- Pfizer stock a buy as company moves beyond COVID, Barron's says
- 02/01/23
- Novavax refuses to refund $700M for COVID shots never delivered, NY Times says
- 01/13/23
- Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports
- 01/11/23
- Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says
- 12/30/22
- Merck's Covid treatment gets conditional approval in China, Reuters reports
- 09/30/22
- Jury awards $293M in damages to Monster from rival Bang Energy, Reuters reports
- 03/06/23
- New diabetes drugs altering how patients are treated, WSJ reports
- 12/19/22
- Eli Lilly's Mounjaro, Trulicity added to FDA shortage list, STATNews reports
- 10/11/22
- New quality issues found at Eli Lilly drug plant, Reuters reports
- 12/27/22
- Changes at Disney, a Stitch Fix deal among The Information's 2023 predictions
- 10/31/22
- Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 11/12/22
- Housing stocks have rallied, but could start falling again, Barron's says
- 01/04/23
- Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 03/03/23
- Apple executive in charge of cloud initiatives stepping down, Bloomberg reports
- 03/03/23
- Foxconn plans $700M investment in India plant, Bloomberg reports
- 03/02/23
- ESPN looking to be hub of all live sports streaming, CNBC reports
- 03/02/23
- 2023 iPhone to be powered by TSMC's 3nm SoC, DigiTimes reports
- 03/01/23
- Fly Intel: Pre-market Movers
- 03/06/23
- Fly Intel: Pre-market Movers
- 02/21/23
- What You Missed On Wall Street On Tuesday
- 02/21/23
- What You Missed On Wall Street This Morning
- 03/03/23
- Here's What You Missed in Crypto This Week
- 03/02/23
- What You Missed On Wall Street On Thursday
- 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 02/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/27/23
- What You Missed On Wall Street On Monday
- 02/27/23
- What You Missed On Wall Street This Morning
- 02/27/23
- Fly Intel: Pre-market Movers
NATI National Instruments - 01/17/23
- What You Missed On Wall Street This Morning
- 01/13/23
- What You Missed On Wall Street On Friday
- 09/19/22
- What You Missed On Wall Street On Monday
- 09/19/22
- What You Missed On Wall Street This Morning
- 09/19/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/25/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 02/23/23
- What You Missed On Wall Street On Thursday
- 02/23/23
- What You Missed On Wall Street This Morning
- 03/06/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/01/23
- What You Missed On Wall Street On Wednesday
- 03/01/23
- What You Missed On Wall Street This Morning
- 02/28/23
- Fly Intel: After-Hours Movers
- 02/02/23
- What You Missed On Wall Street On Thursday
- 02/02/23
- What You Missed On Wall Street This Morning
- 01/13/23
- What You Missed On Wall Street This Morning
- 01/12/23
- Fly Intel: Pre-market Movers
- 02/24/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/13/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/08/22
- What You Missed On Wall Street On Thursday
- 02/08/23
- What You Missed On Wall Street This Morning
- 02/08/23
- Fly Intel: Pre-market Movers
- 01/17/23
- What You Missed On Wall Street On Tuesday
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/24/23
- What You Missed On Wall Street This Morning
- 11/09/22
- Fly Intel: Pre-market Movers
- 02/02/23
- Fly Intel: Pre-market Movers
- 01/17/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- Biotech Alert: Searches spiking for these stocks today
- 03/03/23
- Fly Intel: Pre-market Movers
- 03/01/23
- #SocialStocks: Meta leverages artificial intelligence throughout subsidiaries
- 09/12/22
- Wendy's call buyer realizes 30% same-day gains
- 03/06/23
- Unusually active option classes on open March 6th
- 03/06/23
- Notable open interest changes for March 6th
- 03/03/23
- Notable open interest changes for March 3rd
- 02/15/23
- Silvergate Capital Corp call volume above normal and directionally bullish
- 02/08/23
- Largest borrow rate increases among liquid names
- 12/08/22
- Restoration Hardware options imply 7.8% move in share price post-earnings
- 10/24/22
- Restoration Hardware put volume heavy and directionally bearish
- 09/08/22
- Restoration Hardware options imply 7.3% move in share price post-earnings
- 01/31/23
- Unusually active option classes on open January 31st
- 01/11/23
- Largest borrow rate increases among liquid names
- 01/10/23
- Unusually active option classes on open January 10th
- 11/14/22
- Pfizer call volume above normal and directionally bullish
NATI National Instruments - 03/01/23
- National Instruments call volume above normal and directionally bullish
- 01/10/23
- Largest borrow rate increases among liquid names
- 12/07/22
- Largest borrow rate increases among liquid names
- 11/14/22
- Early notable gainers among liquid option names on November 14th
- 10/10/22
- Early notable gainers among liquid option names on October 10th
- 03/02/23
- Early notable gainers among liquid option names on March 2nd
- 11/01/22
- Unusually active option classes on open November 1st
- 10/03/22
- Eli Lilly And Co put volume heavy and directionally bearish
- 09/28/22
- Early notable gainers among liquid option names on September 28th
- 09/28/22
- Unusually active option classes on open September 28th
- 02/09/23
- Unusually active option classes on open February 9th
- 02/08/23
- KB Home put volume heavy and directionally bearish
- 01/11/23
- KB Home options imply 4.2% move in share price post-earnings
- 12/07/22
- KB Home put volume heavy and directionally bearish
- 12/07/22
- Hashicorp options imply 11.3% move in share price post-earnings
- 02/17/23
- D R Horton put volume heavy and directionally bearish
- 02/03/23
- D R Horton put volume heavy and directionally bearish
- 01/19/23
- D R Horton put volume heavy and directionally bearish
- 11/09/22
- Early notable gainers among liquid option names on November 9th
- 02/24/23
- Bristol Myers Squibb put volume heavy and directionally bearish
- 09/29/22
- Early notable gainers among liquid option names on September 29th
- 09/12/22
- Early notable gainers among liquid option names on September 12th
- 09/12/22
- Unusually active option classes on open September 12th
- 03/02/23
- Notable open interest changes for March 2nd
- 03/01/23
- Notable open interest changes for March 1st
- 02/28/23
- Notable open interest changes for February 28th
|
Upgrade
|
UBS analyst Chris Snyder… UBS analyst Chris Snyder upgraded Emerson Electric (EMR) to Buy from Neutral with a price target of $97, down from $100, following the January 4 downgrade. The firm finds the recent derating overdone, and while UBS has been critical of a potential National Instruments (NATI) deal, thinks the market-implied $10B value erosion "seems excessive," the analyst tells investors in a research note. Assuming an $8B acquisition of National Instruments, the firm's math suggests Emerson still has $4B incremental dry powder. ShowHide Related Items >><< - 01/23/23
- Emerson Electric issues statement regarding National Instruments proposal
- 01/17/23
- National Instruments reiterates commitment to strategic review process
- 01/17/23
- National Instruments confirms receipt of acquisition proposal from Emerson
- 01/17/23
- Emerson Electric 'disappointed' National Instruments chose to announce review
- 02/21/23 TD Cowen
- Emerson Electric price target lowered to $105 from $115 at Cowen
- 02/14/23 Argus
- Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
- 02/14/23 Argus
- Emerson Electric downgraded to Hold from Buy at Argus
- 02/09/23 Deutsche Bank
- Deutsche Bank keeps Hold on Emerson Electric, lowers price target to $93
NATI National Instruments - 02/01/23 Baird
- National Instruments downgraded to Neutral from Outperform at Baird
- 01/18/23 Baird
- Aspen Technology price target lowered to $224 from $242 at Baird
- 01/17/23 Deutsche Bank
- Emerson makes hostile bid for National Instruments, says Deutsche Bank
- 01/17/23 Baird
- National Instruments price target raised to $50 from $46 at Baird
NATI National Instruments - 01/31/23
- National Instruments sees Q1 adjusted EPS 48c-62c, consensus 47c
- 01/31/23
- National Instruments reports Q4 adjusted EPS 63c, consensus 64c
- 10/27/22
- National Instruments sees Q4 non-GAP EPS 54c-68c, consensus 76c
- 10/27/22
- National Instruments reports Q3 non-GAAP EPS 53c, consensus 53c
- 02/08/23
- Emerson Electric backs FY23 adjusted EPS view $4.00-$4.15, consensus $4.08
- 02/08/23
- Emerson Electric sees Q2 adjusted EPS 95c-$1.00, consensus $1.00
- 02/08/23
- Emerson Electric reports Q1 adjusted EPS 78c, consensus 88c
- 10/31/22
- Emerson Electric sees FY23 adjusted EPS $4.00-$4.15, consensus $5.08
- 10/31/22
- Blackstone to buy 55% stake in Emerson unit in $14B deal, WSJ reports
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
- 10/04/22
- Blackstone in talks to acquire select Emerson assets, Bloomberg says
NATI National Instruments - 01/13/23
- What You Missed On Wall Street On Friday
- 01/13/23
- What You Missed On Wall Street This Morning
- 02/08/23
- What You Missed On Wall Street This Morning
- 02/08/23
- Fly Intel: Pre-market Movers
- 01/17/23
- What You Missed On Wall Street On Tuesday
- 01/17/23
- What You Missed On Wall Street This Morning
NATI National Instruments - 03/01/23
- National Instruments call volume above normal and directionally bullish
|